TY - JOUR
T1 - Fecal occult blood test—the importance of proper evaluation
AU - Niv, Yaron
PY - 1990/8
Y1 - 1990/8
N2 - Fecal occult blood testing is used worldwide to screen for early detection of colorectal neoplasia. Because processing Hemoccult II cards is not difficult, it is very easy for inexperienced personnel to perform, and opens a way to overdiagnose positive tests. This could be followed by unnecessary, expensive diagnostic procedures and a significant decline in the test specificity. In a prospective study of two similar populations (two kibbutzim of the Upper Galilee in northern Israel), I compared the impact of processing the Hemoccult II cards on their positive predictive value for colonic cancer and adenomatous polyps. The inexperienced processor increased overall screening positivity fourfold (25 versus 6%, p < 0.01). This was accompanied by a sharp decrease in the predictive value for adenomas greater than 1 cm (6 versus 25%, p < 0.05) with no change in the final screening yield: 1.58 versus 1.53% of the participants had adenomas in kibbutz A and kibbutz B, respectively. I recommend that the Hemoccult II cards be processed by experienced personnel only.
AB - Fecal occult blood testing is used worldwide to screen for early detection of colorectal neoplasia. Because processing Hemoccult II cards is not difficult, it is very easy for inexperienced personnel to perform, and opens a way to overdiagnose positive tests. This could be followed by unnecessary, expensive diagnostic procedures and a significant decline in the test specificity. In a prospective study of two similar populations (two kibbutzim of the Upper Galilee in northern Israel), I compared the impact of processing the Hemoccult II cards on their positive predictive value for colonic cancer and adenomatous polyps. The inexperienced processor increased overall screening positivity fourfold (25 versus 6%, p < 0.01). This was accompanied by a sharp decrease in the predictive value for adenomas greater than 1 cm (6 versus 25%, p < 0.05) with no change in the final screening yield: 1.58 versus 1.53% of the participants had adenomas in kibbutz A and kibbutz B, respectively. I recommend that the Hemoccult II cards be processed by experienced personnel only.
KW - Colorectal cancer
KW - Hemoccult
KW - Screening program
UR - http://www.scopus.com/inward/record.url?scp=0025272069&partnerID=8YFLogxK
U2 - 10.1097/00004836-199008000-00007
DO - 10.1097/00004836-199008000-00007
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 2398247
AN - SCOPUS:0025272069
SN - 0192-0790
VL - 12
SP - 393
EP - 395
JO - Journal of Clinical Gastroenterology
JF - Journal of Clinical Gastroenterology
IS - 4
ER -